The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW’s Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news. Last week, figures showed the number of women in biotech leadership has stalled. Elsewhere, could… Read More
The types of fats we consume directly impacts the survival and strength of the body’s immune cells and ability to fight disease, researchers have found. A University of Queensland team led an international collaboration that found diet could change the fat composition inside… Read More
New data on Molecular Partners’ radiotherapy candidate MP0712 shows targeted delivery into cancer tumours. MP0712 is being developed for the treatment of patients with small cell lung cancer (SCLC) and other neuroendocrine cancers. The candidate, which targets DLL3, showed potential to deliver radiotherapy treatment to tumours with… Read More
Advances in cancer therapy have produced powerful treatments that can greatly improve survival – but can also trigger fearsome side-effects. Notably, CAR-T cell therapies can cause cytokine release syndrome (CRS). Managing CRS is an area that is becoming increasingly important to Big Pharma, reports DDW’s Megan Thomas. CAR-T cell cancer… Read More
A paper published in Nature Communications by a team of researchers from Oxford and North Carolina provides structural insights into human brachyury DNA recognition and discovery of progressible binders for cancer therapy. Unpacking brachyury According to the paper’s abstract1, Brachyury is a transcription factor that affects tumour growth of the… Read More
